Contact this trialFirst, we need to learn more about you.
Central Nervous System Stimulant
Quillivant XR for ADHD in Down Syndrome
Recruiting3 awardsPhase 4
Boston, Massachusetts
This trial will help determine the feasibility and effectiveness of stimulant medication for treating ADHD in children with Down syndrome.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service